8C11

BRD4 in complex with 2-(2-(4-(3,5-dimethylisoxazol-4-yl)-1H-pyrazol-1-yl)acetamido)-N-ethylpropanamide

• PDB DOI: https://doi.org/10.2210/pdb8C11/pdb

• Classification: TRANSCRIPTION
• Organism(s): Homo sapiens
• Expression System: Escherichia coli BL21(DE3)
• Mutation(s): No 


• Deposited: 2022-12-19 Released: 2023-12-27 
• Deposition Author(s): Martin, M.P., Noble, M.E.N.
• Funding Organization(s): Engineering and Physical Sciences Research Council, Cancer Research UK

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.80 Å
• R-Value Free: 0.234 
• R-Value Work: 0.195 

Literature

BRD4 complex with compound 22

Waring, M.J.

To be published.

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors and generated by PISA (software)

Biological Assembly Evidence: gel filtration

Macromolecule Content

• Total Structure Weight: 15.68 kDa 
• Atom Count: 1,224 
• Modelled Residue Count: 129 
• Deposited Residue Count: 129 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Bromodomain-containing protein 4	A	129	Homo sapiens	Mutation(s): 0  Gene Names: BRD4, HUNK1
UniProt & NIH Common Fund Data Resources
Find proteins for O60885 (Homo sapiens) Explore O60885  Go to UniProtKB:  O60885
PHAROS:  O60885 GTEx:  ENSG00000141867

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
SY0 (Subject of Investigation/LOI)	B [auth A]	(2~{S})-2-[2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazol-1-yl]ethanoylamino]-~{N}-ethyl-propanamide C15 H21 N5 O3 UJPHDNXNLWIDIQ-JTQLQIEISA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.80 Å
• R-Value Free: 0.234 
• R-Value Work: 0.195 
• Space Group: P 2₁ 2₁ 2₁

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 38.144	α = 90
b = 43.237	β = 90
c = 79.276	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
PROTEUM PLUS	data reduction
Aimless	data scaling
PHASER	phasing

Structure Validation

Entry History & Funding Information

Deposition Data

• Released Date: 2023-12-27 
Deposition Author(s): Martin, M.P., Noble, M.E.N.

---

Funding Organization	Location	Grant Number
Engineering and Physical Sciences Research Council	United Kingdom	MoSMed CDT/ EP/S022791/1
Cancer Research UK	United Kingdom	C2115/A21421
Cancer Research UK	United Kingdom	DRCDDRPGMAPR/100002
Cancer Research UK	United Kingdom	A20263

Revision History  

• Version 1.0: 2023-12-27
  Type: Initial release